Beware Marketing Cannabidiol Products: FDA Is Watching
By Brian Malkin, James Ravitz and Emily LeonginiDecember 5, 2017, 2:18 PM EST
Law360, New York (December 5, 2017, 2:18 PM EST) -- The U.S. Food and Drug Administration recently issued warning letters to four companies — Stanley Brothers Social Enterprises LLC, Greenroads Health, Natural Alchemist, and That’s Natural! Marketing and Consulting — that market edibles, oils, tinctures, capsules and topical creams containing cannabidiol (CBD), a nonpsychotropic cannabinoid found in cannabis.
Although the violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) cited in these letters are nothing new (the FDA sent similar letters to more than a dozen CBD companies in 2015 and 2016), they should...